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ABSTRACT: A novel 1:1 cocrystal between p-toluenesulfonamide and triphenylphosphine oxide has 
been prepared and structurally characterized.  This 1:1 cocrystal was observed to form during solid state 
grinding experiments, with subsequent formation of a known 3:2 cocrystal in the presence of excess 
sulfonamide. Both cocrystals are stable in the solid state. The ternary phase diagram for the two 
coformers was constructed in two different solvents: acetonitrile and dichloromethane. Examination of 
these diagrams clarified solution crystallization of both the newly discovered 1:1 cocrystal and the 
previously reported 3:2 cocrystal, and identified regions of stability for each cocrystal in each solvent.  
The choice of solvent was found to have a significant effect on the position of the solid state regions 
within a cocrystal system. 
 
Introduction 
Cocrystals, crystalline structures composed of two or more neutral components, have the potential to 
alter the physical properties of solid state materials, and as such are of great interest to the 
pharmaceutical industry.
1
 Research in cocrystallization has greatly increased in recent years; yet large 
scale production of a commercial cocrystal product remains elusive. This is mainly due to a lack of 
robustness in cocrystal preparation methods. Solid state grinding, solvent drop grinding and solution 
methods are routinely used to produce cocrystals,
2-3
 but with a certain element of trial and error 
involved. The majority of the work to date has focused on discovery of new cocrystal structures, 
although there has been recent work on understanding the mechanism of formation of cocrystals,
4-10
 as 
well as combining prediction and experiment to design novel cocrystal forms.
11
 
Ternary phase diagrams can be used to describe the stability of a desired cocrystal in terms of the 
concentration of both of the coformers in a given solvent.
4-10
 Chiarella et al. used ternary phase 
diagrams to understand the formation of a 1:1 cocrystal of trans-cinnamic acid and nicotinamide.
4
 
Evaporation of a solution containing stoichiometric amounts of both coformers in methanol yielded the 
cocrystal, but in water gave only the acid. A phase diagram was constructed by allowing the coformers 
and the cocrystal to equilibrate individually in methanol and water, with varying coformer ratios. In 
methanol, it was observed that the solubility curve of the cocrystal crossed the 1:1 stoichiometric ratio 
line, meaning that it is possible to crystallize the cocrystal from a stoichiometic solution in methanol. In 
 4 
water the cocrystal solubility curve does not cross the 1:1 stoichiometric ratio line, and thus it is not 
possible to obtain the cocrystal from a stoichiometric aqueous solution. Rodríguez-Hornedo et al. made 
use of a ternary phase diagram to describe the stability of two cocrystals (2:1 and 1:1 ratios) of 
carbamazepine with 4-aminobenzoic acid.
7
  Both cocrystals could be obtained from slow evaporation of 
solutions of the coformers in ethanol, with the cocrystal stochiometry dictated by the acid concentration. 
Billot et al. used discontinuous isoperibolic thermal analysis (DITA) to produce phase diagrams of an 
API and glutaric acid in a range of different solvents, and used the results to build a predictive model for 
cocrystal stability in alternative solvents.
5
 A number of authors have reviewed the thermodynamics 
involved in cocrystal formation.
9,12-14
 
Triphenylphosphine oxide (Ph3PO) is an excellent hydrogen-bond acceptor and has therefore attracted 
attention as a cocrystal coformer.
15
 Sulfonamides have also been used as coformers due to their 
hydrogen-bond donor ability, for example as recently shown by Nangia et al.
16
 The commonly observed 
motif is the R
2
 4 (8) ring, usually with a 1:1 stoichiometry. Glidewell et al. reported a 3:2 cocrystal of p-
toluenesulfonamide (TSA) with Ph3PO,
17
 as well as a 1:1 cocrystal of TSA with the related m-
tritolylphosphine oxide.
18 
(a) (b)
 
Figure 1: Chemical structure of (a) p-toluenesulfonamide (M.P.=134-137 
o
C), and (b) 
triphenylphosphine oxide (M.P. = 154-158 
o
 C). 
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The cocrystallization of TSA with Ph3PO was investigated, and herein we report a new 1:1 cocrystal 
of TSA with Ph3PO. The formation of the two cocrystals was investigated in the solid state and in 
solution, and ternary phase diagrams were constructed to identify regions of stability for each cocrystal 
in two solvents, acetonitrile and dichloromethane.   
 
Experimental Section 
Chemicals. p-Toluenesulfonamide and triphenylphosphine oxide were obtained from Sigma and used 
as received. Acetonitrile and dichloromethane were reagent grade. 
Solid State Grinding Experiments 
 Grinding experiments were performed using a Retsch MM400 ball mill fitted with 5 mL grinding jars 
containing one 2.5 mm stainless steel grinding ball per jar. The mill was operated at 30 Hz frequency. 
The initial experiment involved grinding a 1:1 ratio of the two coformers for 30 min on a 1 mmol scale. 
Subsequent experiments were undertaken on a 1 mmol as detailed in Tables 1 and 2.  
Crystallization Experiments 
p-Toluenesulfonamide (0.171 g, 1.00 mmol) and triphenylphosphine oxide (0.278 g, 1.00 mmol) were 
dissolved in MeCN (6 mL) and placed in a sample vial. Toluene (4 mL) was layered on top of the 
solution, and the system left to stand for 21 d to give crystals suitable for single crystal diffraction. 
p-Toluenesulfonamide (0.171 g, 1.00 mmol) and triphenylphosphine oxide (0.278 g, 1.00 mmol) were 
dissolved in CH2Cl2 (10 mL), placed in a sample vial and left to stand for 14 d to give crystals suitable 
for single crystal diffraction. 
Large amounts of each cocrystal form were produced by cooling crystallization in a HEL Polyblock
TM
 
– a glass reaction vessel with automated heating and cooling provided by a Julabo UC012T-H 
Unichiller. For the 3:2 cocrystal, p-toluenesulfonamide (2.57 g, 0.015 mmol) and triphenylphosphine 
oxide (4.17 g, 0.015 mmol) were dissolved in CH2Cl2 (50 mL), heated to reflux and maintained under 
reflux for 1 h. For the 1:1 cocrystal, p-toluenesulfonamide (5.60 g, 0.033 mmol) and triphenylphosphine 
oxide (11.23 g, 0.040 mmol) were dissolved in MeCN (50 mL), heated to 70 
o
C and maintained at this 
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temperature for 1 h. The solutions were cooled at 0. 1 ° C min
-1
 to 5 ° C, and aged for 24 h. The crystals 
were isolated, washed with the pure crystallization solvent (~10 mL) and dried in a vacuum oven at 50 
°C overnight. Cocrystal form was verified using PXRD. 
Solubility Measurements 
The solubility of pure TSA and Ph3PO respectively in MeCN and CH2Cl2 was determined 
gravimetrically. Excess solid was charged to solvent at 20 
o
C and equilibrated with constant agitation for 
24 hours, at which point agitation was stopped and the solids allowed to settle for 1 hour. Three 1 ml 
samples of the clear solution were filtered into preweighed glass vials (M1), and weighed (M2). The 
solvent was allowed to evaporate in a fume hood (24 hours) before transferring the glass vial to a 
vacuum oven at 50 
o
 C (overnight). The vial was allowed to return to room temperature before weighing 
the final dry weight (M3). The formula (M3 – M1)/(M2 – M3) revealed the solubility, expressed as g 
solid/g solvent.  
The solubility of pure TSA and the 1:1 cocrystal as a function of Ph3PO concentration in MeCN and 
CH2Cl2 was determined at 20 
o
C by equilibrating the desired phase in solutions of known Ph3PO 
concentration. The solubility of pure Ph3PO and the 3:2 cocrystal as a function of TSA concentration in 
MeCN and CH2Cl2 at 20 
o
C by equilibrating the desired phase in solutions of known TSA concentration. 
Gravimetric analysis as described above was used to calculate solubility, with mass balance used to 
account for the mass of the known component.  
 The solubility of the 1:1 cocrystal in MeCN at 20 
o
 C was measured in the same way, but efforts to 
measure the solubility of the 3:2 cocrystal in MeCN, or the 1:1 or 3:2 cocrystal in CH2Cl2, were 
unsuccessful due to transformation of the solid form within the equilibration time.  
Invariant points, also referred to as eutectic points or transition concentrations, are fixed solution 
concentrations at which 2 solid phases can exist together in equilibrium; in the present work namely 
TSA and the 3:2 cocrystal (C1), the 3:2 cocrystal and the 1:1 cocrystal (C2), and the 1:1 cocrystal and 
Ph3PO (C3). These points were determined by generating a slurry of the 2 required solid forms, 
described as (C1), (C2), (C3) above, using the method described by Rodríguez-Hornedo et al.
14
 The 
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slurries were equilibrated for 24 h at 20 °C, after which the solvent content of the liquid phase was 
determined using gravimetric analysis, and the concentration of TSA and Ph3PO in the liquid phase was 
determined using HPLC.  
The experimental setup for all solubility measurements consisted of a thermostatic water bath (Grant 
GR150 with S38 stainless steel water bath; 26 L; stability ± 0.005 °C and uniformity ± 0.02 °C @ 37 
°C) with a serial magnetic stirrer plate placed on the base. Agitation was provided by use of 10 mm 
magnetic stirrer bars in 5 ml glass vials. 
Construction of the Ternary Phase Diagram 
The solubility of the pure substances and the invariant points were converted to mass fraction on a 
total mass basis (TSA + Ph3PO + Solvent), and plotted on a ternary axis in both MeCN and CH2Cl2 to 
generate the appropriate ternary phase diagrams using ProSim Ternary Diagram software. Mass fraction 
was chosen in preference to mole fraction as the use of mole fraction tended to compress the solution 
phase region making visualization of the solubility curves difficult. 
Differential Scanning Calorimetry 
 DSC was performed on a TA instruments Q1000 incorporating a refrigerated cooling system. 
Samples (3–5 mg) were crimped in non-hermetic aluminum pans and scanned from 30 to 300 °C at a 
heating rate of 10 °C/min under a continuously purged dry nitrogen atmosphere. 
Single Crystal Diffraction 
X-ray diffraction data were collected on a Bruker APEX II DUO diffractometer using graphite 
monochromatized Mo K radiation ( = 0.7107 Å), and cooled using an Oxford Cryosystems COBRA 
fitted with a N2 generator. All calculations were performed using the APEX2 software suite,
19,20
 and the 
diagrams prepared using Mercury 2.4.
21
 
Powder Diffraction 
 Powder diffraction data were collected on either a Philips X’Pert-MPD PRO diffractometer with 
nickel filtered copper Cu K radiation ( = 1.5418 Å), run at 40 kV and 35 mA, 2 = 5 – 35°, with a 
step size of 0.02 2  and a scan speed of 0.02 s-1, or on a Stöe Stadi MP diffractometer with Cu K 
 8 
radiation ( = 1.5406 Å) run at 40 kV and 40 mA, 2 = 3.5 – 60°, with a step size of 0.5 2  and a step 
time of 30s. 
HPLC Analysis 
 This was performed on either a Waters Alliance 2690 Separations Module with a Waters 486 
Detector using a YMC-Pack ODS-A column (250 mm x 4.6 mm, 5 µm) eluting with MeCN:H2O 
(60:40) at 1 mL/min, UV detection at 254 nm, or on a HPLC System consisting of a Shimadzu LC10AT 
Pump set at 1.5mL/min, Shimadzu SPD-6AV Spectrophotometric detector at 254 nm, a Waters 717 
autosampler with a Beckman Coulter Ultrasphere ODS Column (250 mm x 4.5 mm, 5 µm), eluting with 
MeCN:H2O (60:40). 
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Results and Discussion 
Solid state grinding 
Solid state grinding of an equimolar mixture of TSA and Ph3PO for 30 min yielded a product which 
showed the presence of two sharp endothermic peaks at 135 and 139 °C in the DSC analysis, Figure 2. 
The 3:2 cocrystal is known to have a melting point of 138 °C.
17
 The PXRD pattern of this product 
showed the presence of the known 3:2 cocrystal and extra peaks which were not due to an excess of 
either starting material. 
 
Figure 2: DSC trace of the product obtained from 30 minute grinding of a 1:1 molar mixture of TSA and 
Ph3PO. 
Single crystal analysis of crystals obtained from MeCN, melting point 134–136 °C, revealed a novel 
1:1 cocrystal (Figure 3). Each amide hydrogen atom is involved in a discrete hydrogen-bond to a 
phosphine oxygen atom, leading to a discrete four molecule hydrogen-bonded complex containing a R
2
 4 
(8) ring at the binary level.
22
 The PXRD data for the unknown material observed in the grinding 
experiments is consistent with the single crystal data for this new 1:1 cocrystal. Crystals grown from 
CH2Cl2, melting point 138–140 °C, were found to match the reported 3:2 structure.
17 
The X-ray 
diffraction pattern of each form was generated in Mercury 2.4 from the respective crystallographic 
information files (CIF) file, and is presented in Figure 4. 
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Figure 3: The cocrystals of TSA with PPh3O: (i) the 1:1 cocrystal, left, showing the R
2
 4 (8) ring and (ii) 
the 3:2 cocrystal,
17
 right, which also has the R
2
 4 (8) motif. 
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Figure 4: PXRD patterns recorded for the 1:1 (A) and 3:2 (B) cocrystals of TSA and Ph3PO. 
Experimental patterns are shown as solid lines with the corresponding theoretical pattern given as a 
dotted line. 
In order to gain some insight into the stability of the cocrystals, we undertook further grinding 
experiments. Thus, a 1:1 molar ratio of the two coformers was ground for either a short time (5 min) or a 
long time (198 min). This was repeated using a 3:2 molar ratio of the coformers. The results (Table 1) 
suggest that the 1:1 cocrystal is formed first, before transforming into the 3:2 cocrystal if sufficient 
sulfonamide is present. 
 
B 
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Table 1. Effect of reagent composition and grinding time upon cocrystal output 
Material input Grind time (min) Material output 
1:1 ratio of coformers 5 1:1 cocrystal, plus both coformers 
1:1 ratio of coformers 198 1:1 cocrystal 
3:2 ratio of coformers 5 1:1 cocrystal, plus both coformers 
3:2 ratio of coformers 198 3:2 cocrystal 
 
Examination of the crystal structures of the 1:1 and 3:2 cocrystals show significant similarity: they 
both possess two terminal PPh3O molecules, with sulfonamide molecules acting as bridges via 
hydrogen-bonding. This suggests that a third sulfonamide can "slot into" the structure of the 1:1 
cocrystal in the grinding experiments to generate the 3:2 cocrystal. 
To test this hypothesis, the following experiments were undertaken: (i) the 1:1 cocrystal was ground 
with TSA in a 1:1 ratio, (ii) the 1:1 cocrystal (1 equivalent) was ground with TSA (2 equivalents), and 
(iii) the 3:2 cocrystal was ground with Ph3PO in a 1:1 ratio (Table 2 and Supporting Information). 
Experiments (i) and (ii) confirm that the 1:1 cocrystal can transform to the 3:2 cocrystal with excess 
sulfonamide present. Experiment (iii) shows that the 3:2 cocrystal does not transform to the 1:1 
cocrystal when ground with an excess of Ph3PO. PXRD analysis indicates no changes to either cocrystal 
over the period of eighteen months. Having examined the stability of the cocrystals in the solid state, we 
proceeded to undertake solution based stability studies. 
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Table 2. Effect of grinding the cocrystal with one coformer 
Material input Grind time (min) Material output 
1:1 cocrystal with TSA (1:1 ratio) 20 3:2 cocrystal plus TSA 
1:1 cocrystal with TSA (2:1 ratio) 20 3:2 cocrystal 
3:2 cocrystal with Ph3PO (1:1 ratio) 20 3:2 cocrystal plus Ph3PO 
 
Solubility Measurements 
The solubility values for TSA and Ph3PO in each solvent at 20 °C are listed in Table 3. The order of 
solubility between TSA and Ph3PO varies in the two solvents: TSA is more soluble than Ph3PO in 
MeCN, but much less soluble than Ph3PO in CH2Cl2. Ph3PO is extremely soluble in CH2Cl2, exceeding 
the solubility of TSA by a factor of 35. It has been reported that the relative solubilities of the two 
cocrystal components in a solvent can be used to prepare a cocrystal in that solvent
4
, and a screening 
method has been developed around this concept.
23
  
Production of pure cocrystal forms using cooling crystallization was confirmed using PXRD (Figure 
4). The solubility of the 1:1 cocrystal was successfully determined in MeCN. The concentration of TSA 
in a solution in equilibrium with the 1:1 cocrystal is lower than the concentration of TSA in a solution in 
equilibrium with pure TSA. The solubility of the 3:2 cocrystal could not be determined in MeCN. 
Equilibration of the 3:2 cocrystal in MeCN resulted in formation of the 1:1 cocrystal within 24 hours, a 
phenomenon known as incongruent dissolution.   
Both cocrystals dissolved incongruently in CH2Cl2. Equilibration of the 3:2 cocrystal resulted in the 
formation of pure TSA, and equilibration of the 1:1 cocrystal resulted in the production of a mixture of 
the 3:2 cocrystal and TSA.  Incongruent dissolution is an indication of an unsymmetrical ternary phase 
diagram, and usually occurs when there is a large difference in solubility between the 2 pure conforming 
phases in that solvent. 
4 
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Table 3. Measured Solubility Values for each Solid Form in MeCN and CH2Cl2 at 20 °C, Expressed in 
Terms of Mass Fraction (total mass basis, (MF)), and Molarity [M] 
Solid Solvent Solubility Solid Phase 
at end of 
equilibration MFTSA MFPh3PO MFsolvent [M] 
TSA MeCN 0.23 - 0.77 1.38 TSA 
Ph3PO - 0.13 0.87
 
0.40
 
Ph3PO 
1:1 Cocrystal 0.04 0.06 0.90 0.19 1:1  
3:2 Cocrystal N/A  1:1 
TSA CH2Cl2 0.01 - 0.99 0.11 TSA 
Ph3PO - 0.44 0.56 3.80 Ph3PO 
1:1 Cocrystal N/A  3:2 + TSA 
3:2 Cocrystal N/A  TSA 
 
Experimentally determined invariant points in each solvent are expressed in terms of mass fraction in 
Table 4. 
Table 4. Invariant points in MeCN and CH2Cl2 at 20 °C 
Solvent Solid forms in 
equilibrium 
Invariant Point (mass fraction, total mass basis) 
XTSA XPh3PO XSolvent 
MeCN TSA + 3:2 (C1) 0.195 0.014 0.791 
3:2 + 1:1(C2) 0.087 0.041 0.871 
1:1 + Ph3PO (C3) 0.018 0.150 0.832 
CH2Cl2 TSA + 3:2 (C1) 0.047 0.075 0.878 
3:2 + 1:1 (C2) 0.035 0.205 0.760 
1:1 + Ph3PO (C3) 0.031 0.357 0.612 
 
The ternary phase diagrams in MeCN and CH2Cl2 are presented in Figure 5 and Figure 6 respectively.  
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Figure 5: Ternary Phase Diagram for the TSA – Ph3PO – MeCN system at 20 °C. Regions in the 
diagram are as follows: (1) solution phase;  all other regions consist of a saturated solution in contact 
with (2) TSA only, (3) TSA + 3:2 cocrystal, (4) 3:2 cocrystal only, (5) 3:2 cocrystal + 1:1 cocrystal, (6) 
1:1 cocrystal only, (7) 1:1 cocrystal + Ph3PO, and, (8) Ph3PO only. Values are in mass fractions. 
TSA and Ph3PO have a reasonably similar solubility in MeCN resulting in an approximately 
symmetrical ternary phase diagram. The 3:2 (region 4) and 1:1 (region 6) cocrystal are independently 
stable across a wide range of solution compositions. The 1:1 component stoichiometric line (solid line) 
intersects the solubility curve for the 1:1 cocrystal, indicating congruent dissolution for this cocrystal. 
Dissolution of the 1:1 cocrystal results in a solution with 1:1 molar stoichiometry, making it possible to 
experimentally measure the solubility of the 1:1 cocrystal in MeCN. In contrast, the 3:2 component 
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stoichiometric line (dashed line) does not intersect the solubility curve of the 3:2 cocrystal, explaining 
the observed incongruent dissolution of this form. This line instead intersects the solubility curve for the 
1:1 cocrystal. Dissolution of the 3:2 cocrystal results in establishment of an equilibrium between a 
saturated solution and the 1:1 cocrystal. 
In CH2Cl2 the significant difference in solubility between TSA and Ph3PO results in an unsymmetrical 
diagram, with all regions skewed towards the Ph3PO axis of the diagram. Both cocrystals dissolve 
incongruently, with dissolution of the 3:2 cocrystal initially resulting in solution of invariant 
composition in equilibrium with the 3:2 cocrystal and pure TSA (region 3), potentially continuing to a 
solution in equilibrium with pure TSA (region 2). Dissolution of the 1:1 cocrystal initially results in 
generation of a solution saturated with respect to the 1:1 and the 3:2 cocrystal (region 5), with continued 
dissolution resulting in solution composition moving to region 4, the region of stability for the 3:2 
cocrystal. The 1:1 component stoichiometric line will eventually pass through the C1 invariant point on 
this diagram, resulting in a saturated solution of invariant composition in equilibrium with the 3:2 
cocrystal and pure TSA. In each case, the extent of dissolution will be controlled by the mass of the 
solvent present. The diagram is in good agreement with the phase conversions observed during efforts to 
measure cocrystal solubility (Table 3). 
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Figure 6: Ternary Phase Diagram for the TSA – Ph3PO – CH2Cl2 system at 20 °C. Regions in the 
diagram are as follows: (1) solution phase;  all other regions consist of a saturated solution in contact 
with (2) TSA only, (3) TSA + 3:2 cocrystal, (4) 3:2 cocrystal only, (5) 3:2 cocrystal + 1:1 cocrystal, (6) 
1:1 cocrystal only, (7) 1:1 cocrystal + Ph3PO, and, (8) Ph3PO only. Values are in mass fraction, total 
mass basis. 
Evaporation from a solution of 1:1 molar composition in either solvent may be visualized by 
following the solid line from the top apex of the diagram to the 1:1 cocrystal composition point. In 
MeCN, this line passes straight through region 6 making it possible to isolate the 1:1 cocrystal from this 
solution, regardless of the point at which evaporation is stopped. In CH2Cl2, evaporation of a solution of 
1:1 molar composition could initially result in crystallization of pure TSA as the solid line skims the 
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solubility curve for TSA. Continued evaporation will move the solution composition into region 4, 
making it possible to isolate a pure 3:2 cocrystal product, but only if evaporation is stopped within this 
region. Further evaporation will result in concomitant crystallization of the 1:1 cocrystal as the solution 
composition moves into region 5. This demonstrates that the product of an evaporative crystallization 
can be dependent on the extent of solvent evaporation in a cocrystallization experiment, depending on 
the shape of the ternary phase diagram. A ternary phase diagram represents a system at thermodynamic 
equilibrium, and the above discussion is based on the assumption that thermodynamic equilibrium is 
maintained during the evaporation process.  Crystallization is a dynamic process in which kinetic and 
thermodynamic factors compete to determine the solid product form, with kinetic factors most likely to 
promote the formation of a metastable product, but this is not specifically addressed in this work.  
The same seven solid form regions (regions 2-8) were observed in each solvent, but the choice of 
solvent did affect the positioning of each solid form region within the ternary phase diagram. The shape 
of a ternary phase diagram is dependent on the relative solubility of both coformers in that solvent. 
Selection of a solvent which has a particular affinity for either, or both, coformers is a means of 
controlling the shape of the ternary phase diagram, and the region of stability for the desired crystal 
form. 
 
Conclusions 
A novel 1:1 cocrystal of p-toluenesulfonamide and triphenylphosphine oxide has been obtained by 
crystallizing the two coformers from acetonitrile, and single crystal analysis successfully applied to 
identify the new crystal structure. The 1:1 cocrystal has some structural similarity to the known 3:2 
cocrystal, with the latter related by a simple incorporation of an extra sulfonamide molecule between 
two bridging phosphine oxide molecules. 
Construction of the ternary phase diagram for p-toluenesulfonamide and triphenylphosphine oxide in 
MeCN and CH2Cl2 clearly identified regions of stability for the 1:1 and 3:2 cocrystal in these solvents,  
allowing for rationalization of the experimental isolation of the 1:1 cocrystal from a solution of 1:1 
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molar stoichiometry in MeCN, and the 3:2 cocrystal from a solution of 1:1 molar stoichiometry in 
CH2Cl2. This result demonstrates that solution stoichiometry during cocrystal preparation or screening 
does not necessarily reflect the stoichiometry of the resulting cocrystal. The solubility of both cocrystal 
coformers must be taken into consideration when performing a cocrystal search to ensure that cocrystals 
are discovered and that those of different stoichiometry are not missed.  
Congruent and incongruent cocrystal dissolution was observed in MeCN for the 1:1 and the 3:2 
cocrystal respectively, with both cocrystals dissolving incongruently in CH2Cl2.  Incongruent dissolution 
prevents the measurement of pure cocrystal solubility with traditional methods, as it becomes impossible 
to equilibrate the pure cocrystal in the pure solvent to generate the required saturated solution. 
Incongruent dissolution is likely when there is a significant difference between the solubility of the pure 
coformers in the solvent.  
Knowledge of the ternary phase diagram informs effective experimental design to control the desired 
cocrystal form. The choice of solvent in a cocrystal system has a major impact on the shape of the 
resulting ternary phase diagram. 
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A novel 1:1 cocrystal between p-toluenesulfonamide and triphenylphosphine oxide has been 
characterized. The relationship between this cocrystal and an existing 3:2 cocrystal in the solid state has 
been investigated. Ternary phase diagrams involving the two coformers have been constructed in two 
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different solvents, acetonitrile and dichloromethane, giving insight into the stability and solution 
crystallization of the 1:1 cocrystal and the 3:2 cocrystal. 
 
